BREAST-Q IS在澳大利亚乳房器械登记处的重测信度研究
本研究在澳大利亚乳房器械登记处中评估BREAST-Q IS(5问题患者报告结局测量工具)在乳房植入物接受者中的重测信度。共发放250份问卷,207人完成两次测试(间隔2周),乳房 augmentation 组应答率82%(n=113),乳房重建组94%(n=94)。结果显示5个问题的加权kappa系数均高于0.74,表明该工具在登记处环境中具有良好至优秀的重测信度。
要点
- BREAST-Q IS在乳房植入物接受者中重测信度良好至优秀,加权kappa均>0.74。
- 研究纳入乳房 augmentation 和乳房重建两组,间隔2周完成两次测试。
- 该工具可用于登记处监测乳房器械性能,但需进一步验证。
核心结论
- BREAST-Q IS在登记处环境下的乳房植入物接受者中具有良好至优秀的重测信度。
研究设计与样本
- 重测信度研究,纳入澳大利亚乳房器械登记处中接受乳房 augmentation 或乳房重建的患者,共发放250份问卷,间隔2周重复施测。
主要发现
- 共207名参与者完成两次测试,乳房 augmentation 组应答率82%(n=113),乳房重建组94%(n=94)。
- BREAST-Q IS全部5个问题在两组中的加权kappa系数均高于0.74。
关键数值与推荐
- 加权kappa系数均>0.74(具体数值原文未逐一报告)。
- 测试间隔为2周。
临床怎么用
- BREAST-Q IS可作为登记处环境中监测乳房植入物接受者报告结局的可靠工具。
- 仍需进一步验证以确立其作为有效且可靠PROM工具的地位。
局限性
- 原文未明确报告局限性内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patient-reported outcome measures (PROMs) are increasingly employed in healthcare to assess outcomes. The BREAST-Q Implant Surveillance module (BREAST-Q IS) is a 5-question PROM utilized by the Australian Breast Device Registry to monitor the performance of breast devices. Validation of this tool is needed to assess its utility in this setting. OBJECTIVES: The objective of this study was to assess the test-retest reliability of the BREAST-Q IS among breast implant recipients within a registry setting. METHODS: A test-retest reliability study was undertaken. Patients who underwent breast augmentation or breast reconstruction and registered with the Australian Breast Device Registry were eligible to participate. A total of 250 surveys were distributed. The BREAST-Q IS was administered to the same group of participants on 2 separate occasions with a 2-week test interval. Participants were divided into 2 groups: breast augmentation and breast reconstruction. A weighted kappa coefficient was calculated to assess the degree of test-retest reliability of the BREAST-Q IS. RESULTS: A total of 207 participants completed both tests. The response rate was 82% (n = 113) for the breast augmentation group and 94% (n = 94) for the breast reconstruction group. All 5 questions on the BREAST-Q IS obtained weighted kappa scores above 0.74 among both groups. CONCLUSIONS: The BREAST-Q IS has good to excellent test-retest reliability for utilization among breast implant recipients in a registry setting. Further validation of the BREAST-Q IS will be required to establish the BREAST-Q IS as a valid and reliable PROM tool for breast implant recipients following breast device surgery.
引用
- Merenda M, Vishwanath S, Ng S, et al. Test-Retest Reliability of the BREAST-Q IS in the Australian Breast Device Registry. Aesthet Surg J. 2021. PMID: 33289030. doi:10.1093/asj/sjaa342
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。